GAVILAX
NDC 17856-0310, Polyethylene Glycol 3350, powder, for solution, from Atlantic Biologicals Corp..
- Product NDC
- 17856-0310
- Status
- Listed
- Labeler
- Atlantic Biologicals Corp.
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA091077
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0310 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POLYETHYLENE GLYCOL 335017 g/17g
Pharmacologic classes
Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17856-0310-1 | 17856031001 | 50 CUP, UNIT-DOSE in 1 CASE (17856-0310-1) / 2 g in 1 CUP, UNIT-DOSE |
| 17856-0310-2 | 17856031002 | 72 POUCH in 1 CASE (17856-0310-2) / 2 g in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 17856-0310 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17856-0310 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17856-0310. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.